Dr Reddys Laboratories Share Price Today - Live Blog for April 24, 2025

Dr Reddys Laboratories Ltd share price surged by 0.54%. With its current market price standing at ₹1,205.00 per share, this stock is garnering increased attention from the investment community.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.50% upswing and is currently trading at ₹1,204.10, indicating strong market sentiment.

Dr Reddys Laboratories Ltd's shares experienced a 0.54% uptick, and they are currently valued at ₹1,198.25, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1579 and an ROE of 17.3623%.

Dr Reddys Laboratories Ltd witnessed a substantial 0.14% increase in its share price and is currently trading at ₹1,191.85. This remarkable performance has caught the eye of investors.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.10% in its share price, and it currently trades at ₹1,189.20 per share. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd witnessed a -0.09% drop in its share price and is currently trading at ₹1,188.50. With the stock's PE at 18.4200 and the industry PE at 34.3414, investors are weighing their options.

The stock of Dr Reddys Laboratories Ltd suffered a -0.09% decline, and it currently trades at ₹1,189.55 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.18% gain, with the share price now at ₹1,190.65. Notably, the stock's PE ratio stands at 18.4200, and its Return on Equity (ROE) is 17.3623%.

Dr Reddys Laboratories Ltd shares experienced a -0.15% reduction, with the current market price at ₹1,188.20. Investors are carefully considering their positions and seeking insights into the stock's future performance.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.52%, signalling a challenging period. Currently trading at ₹1,189.70, this stock has caught the eye of bargain hunters, who may be considering their entry points.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.35% in its share price, and it currently trades at ₹1,194.10 per share. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd shares experienced a -0.06% reduction, with the current market price at ₹1,199.85. Investors are carefully considering their positions and seeking insights into the stock's future performance.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.13% increase and currently trading at ₹1,199.00 per share. Investors are taking notice of this upward momentum.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.04% in its share price, and it currently trades at ₹1,198.05 per share. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.19%, signalling a challenging period. Currently trading at ₹1,198.60, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd witnessed a notable 0.15% surge in its share price and is presently trading at ₹1,200.85, captivating the attention of market participants.

Dr Reddys Laboratories Ltd's stock price surged by 0.05%, reaching the current market value of ₹1,199.00 per share. This surge is a testament to the stock's recent performance.

The stock of Dr Reddys Laboratories Ltd is facing a -0.08% decline and is currently trading at ₹1,198.45 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd share price has declined by -0.27%, and it's currently trading at ₹1,199.05. The stock maintains a PE of 18.4200, while the industry PE is 34.3414, prompting discussions about its valuation.

The stock of Dr Reddys Laboratories Ltd suffered a -0.27% decline, and it currently trades at ₹1,199.05 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The share price of Dr Reddys Laboratories Ltd experienced a -0.40% slump and is currently trading at ₹1,202.10. While the stock maintains a PE ratio of 18.4200, the industry PE is 34.3414, raising questions about valuation.

Dr Reddys Laboratories Ltd share price surged by 0.65%. With its current market price standing at ₹1,206.90 per share, this stock is garnering increased attention from the investment community.

With a remarkable 0.37% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,197.95. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.4200, while the industry's PE ratio is 34.3414.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.50% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,194.85 per share. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd's share price stayed unchanged, currently trading at ₹1,188.25. The stock has a PE ratio of 18.4200, an ROE of 17.3623%, and a debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd's share price has fallen by -0.59%, a situation worth noting. At present, the stock is trading at ₹1,187.95. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.4200, while the industry PE ratio is 34.3414.